1. Home
  2. GKOS vs TMHC Comparison

GKOS vs TMHC Comparison

Compare GKOS & TMHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GKOS
  • TMHC
  • Stock Information
  • Founded
  • GKOS 1998
  • TMHC 1936
  • Country
  • GKOS United States
  • TMHC United States
  • Employees
  • GKOS N/A
  • TMHC N/A
  • Industry
  • GKOS Medical/Dental Instruments
  • TMHC Homebuilding
  • Sector
  • GKOS Health Care
  • TMHC Consumer Discretionary
  • Exchange
  • GKOS Nasdaq
  • TMHC Nasdaq
  • Market Cap
  • GKOS 7.4B
  • TMHC 7.1B
  • IPO Year
  • GKOS 2015
  • TMHC 2013
  • Fundamental
  • Price
  • GKOS $145.90
  • TMHC $63.39
  • Analyst Decision
  • GKOS Strong Buy
  • TMHC Buy
  • Analyst Count
  • GKOS 13
  • TMHC 8
  • Target Price
  • GKOS $143.00
  • TMHC $85.33
  • AVG Volume (30 Days)
  • GKOS 496.0K
  • TMHC 701.4K
  • Earning Date
  • GKOS 11-04-2024
  • TMHC 02-12-2025
  • Dividend Yield
  • GKOS N/A
  • TMHC N/A
  • EPS Growth
  • GKOS N/A
  • TMHC N/A
  • EPS
  • GKOS N/A
  • TMHC 7.54
  • Revenue
  • GKOS $360,347,000.00
  • TMHC $7,831,512,000.00
  • Revenue This Year
  • GKOS $22.68
  • TMHC $6.42
  • Revenue Next Year
  • GKOS $24.98
  • TMHC $7.33
  • P/E Ratio
  • GKOS N/A
  • TMHC $8.48
  • Revenue Growth
  • GKOS 18.70
  • TMHC N/A
  • 52 Week Low
  • GKOS $74.75
  • TMHC $50.00
  • 52 Week High
  • GKOS $147.65
  • TMHC $75.49
  • Technical
  • Relative Strength Index (RSI)
  • GKOS 58.40
  • TMHC 27.52
  • Support Level
  • GKOS $137.60
  • TMHC $64.23
  • Resistance Level
  • GKOS $147.50
  • TMHC $69.85
  • Average True Range (ATR)
  • GKOS 4.74
  • TMHC 1.72
  • MACD
  • GKOS 0.45
  • TMHC -0.90
  • Stochastic Oscillator
  • GKOS 87.80
  • TMHC 0.58

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. It offers iStent, a micro-bypass stent for insertion in conjunction with cataract surgery for the reduction of intraocular pressure in adult patients with mild-to-moderate open-angle glaucoma. Its product pipeline also consists of an iStent SA trabecular micro-bypass system, a two-stent product that is slightly wider than the iStent Inject and uses a different auto-injection inserter designed for use in a standalone procedure.

About TMHC Taylor Morrison Home Corporation

Taylor Morrison Home Corp is an American residential construction company engaged in residential homebuilding and the development of lifestyle communities. It designs, builds and sells single and multi-family detached and attached homes in traditionally high growth markets for entry level, move-up, and resort lifestyle buyers. The company has four reportable segments: East, Central, West and Financial Services. The majority of the company's revenue is derived from its East Segment.

Share on Social Networks: